Another result pointed out that KAI1/CD82 suppressed adhesion signaling pathways through lateral interactions with α3β1 and α5β1 integrin, thereby inhibiting EMT adhesion of prostate cancer cells to fibronectin matrix and reducing cell migration and invasion ability [59]. The gene discussed is CD82; the disease is prostate carcinoma.